An adamantamine derivative as a drug candidate for the treatment of visceral leishmaniasis.
Sébastien PomelSandrine CojeanValérie PonsJean-Christophe CintratLaetitia NguyenJoël VacusAlain PruvostJinpeng BiDaniel GilletPhilippe M LoiseauPublished in: The Journal of antimicrobial chemotherapy (2021)
VP343 has the properties of a good drug candidate and merits further investigations.